Table 1 Patient demographics and baseline characteristics.
Total (N = 22) | |
|---|---|
Age (years) | |
Mean (SD) | 58.8 (9.7) |
Range | 38.0–78.0 |
Sex (n; %) | |
Female | 13 (59.1) |
Male | 9 (40.9) |
ECOG PS (n; %) | |
0—Fully active | 14 (63.6) |
1—Restricted in physically strenuous activity | 8 (36.4) |
Tumour type (n; %) | |
Colorectal | 5 (22.7) |
Breast | 3 (13.6) |
Sarcoma (of the thigh, uterus and stomach) | 3 (13.6) |
Uterus | 2 (9.1) |
Pancreas | 2 (9.1) |
Liver | 1 (4.5) |
Oesophagus | 1 (4.5) |
Ovary | 1 (4.5) |
Small intestine | 1 (4.5) |
Stomach | 1 (4.5) |
Testicles | 1 (4.5) |
Vater ampulla | 1 (4.5) |
Number of metastatic sites | |
Median (range) | 2 (0–5) |
Prior lines of anticancer therapy (n; %) | |
1 | 1 (4.5) |
2 | 2 (9.1) |
≥3 | 19 (86.4) |
